[RDY] YoY Quarter Result on 30-Sep-2019 [#Q2]

Stock
[RDY] Dr. Reddy's Laboratories Limited
Announcement Date
29-Sep-2019
Financial Year
2020
Quarter
30-Sep-2019 [#Q2]
Profit Trend
QoQ- 64.83%
YoY- 116.85%
Quarter Report
RDY's Result
RDY's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 63,057,000 57,632,000 48,967,000 48,009,000 37,978,000 35,460,000 35,857,000 9.86%
PBT 16,111,000 12,681,000 8,621,000 7,664,000 5,780,000 3,876,000 3,835,000 27.01%
Tax 4,983,000 2,761,000 998,000 -3,261,000 742,000 1,027,000 885,000 33.36%
NP 11,128,000 9,920,000 7,623,000 10,925,000 5,038,000 2,849,000 2,950,000 24.75%
Tax Rate -30.93% -21.77% -11.58% 42.55% -12.84% -26.50% -23.08% -
Total Cost 51,929,000 47,712,000 41,344,000 37,084,000 32,940,000 32,611,000 32,907,000 7.89%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 17.65 17.21 15.57 22.76 13.27 8.03 8.23 13.55%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS 67.40 59.80 45.96 65.93 30.35 17.18 17.80 24.83%
EPS Diluted 66.89 59.65 45.83 65.82 30.31 17.15 17.76 24.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.